Paul D. Rubin - Sep 25, 2024 Form 3 Insider Report for BioAge Labs, Inc. (BIOA)

Role
Chief Medical Officer
Signature
/s/ Dov A. Goldstein as attorney-in-fact
Stock symbol
BIOA
Transactions as of
Sep 25, 2024
Transactions value $
$0
Form type
3
Date filed
9/25/2024, 04:48 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIOA Stock Option (Right to Buy) Sep 25, 2024 Common Stock 90.6K $4.11 Direct F1
holding BIOA Stock Option (Right to Buy) Sep 25, 2024 Common Stock 43.6K $10.27 Direct F2
holding BIOA Stock Option (Right to Buy) Sep 25, 2024 Common Stock 27.4K $6.57 Direct F3
holding BIOA Stock Option (Right to Buy) Sep 25, 2024 Common Stock 27.4K $10.85 Direct F4
holding BIOA Stock Option (Right to Buy) Sep 25, 2024 Common Stock 176K $8.39 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 11, 2024.
F2 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2021, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F3 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F4 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F5 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.